NovoCure (NVCR) Depreciation and Depletion (2014 - 2015)

NovoCure (NVCR) posted quarterly Depreciation and Depletion of -$657000.0 for Q4 2015, down 13.67% year-on-year from -$761014.0 in Q4 2014, and down 13.67% on a QoQ basis from -$578000.0 in Q4 2014.

NovoCure (NVCR) Depreciation and Depletion (2014 - 2015) Analysis & Trends

NovoCure (NVCR) has reported Depreciation and Depletion for 2 consecutive years, with -$657000.0 the latest figure, recorded in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 308.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 89.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 NovoCure 2.28 Bn 1.85 Bn 142.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 -657,000.00
Dec 31, 2015 -657,000.00
Dec 31, 2014 -578,000.00
Dec 31, 2014 -578,000.00